Results 61 to 70 of about 1,695,530 (119)

Reply to Trela, B.A.; Guffroy, M.R. Comment on "AlAsmari et al. Venetoclax Induces Cardiotoxicity Through Modulation of Oxidative-Stress-Mediated Cardiac Inflammation and Apoptosis via NF-κB and BCL-2 Pathway. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 6260". [PDF]

Int J Mol Sci
AlAsmari AF, Alghamdi A, Ali N, Alasmari F.   +3 more
europepmc   +1 more source

Fixed-time treatment of elderly patients with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) using hypomethylating agents and venetoclax - a case series. [PDF]

Ann Hematol
Lindemann A, Göckel G, Garcia-Pardillos G.   +2 more
europepmc   +1 more source

Venetoclax combined with chidamide and decitabine successfully induced remission in relapsed/refractory classical Hodgkin lymphoma: a case report and literature review. [PDF]

Front Immunol
Jin X, Tang Y, Wu Y, Ji J.
europepmc   +1 more source

Safe Accelerated Venetoclax Escalation: a phase 1b study of obinutuzumab plus venetoclax with daily ramp-up in CLL. [PDF]

Blood Adv
Crombie JL, Ahn IE, Ren Y, Tyekucheva S, Carey C, Kniezewski M, Normilus S, Solomon S, Montegaard J, Kim AI, Merryman RW, Armand P, Fisher DC, Brown JR, Davids MS.   +14 more
europepmc   +1 more source

Long-term outcomes of azacitidine, venetoclax, and gilteritinib in newly diagnosed FLT3-mutated AML. [PDF]

Blood Adv
Short NJ, Kantarjian H, Daver N, Azevedo RS, Karrar O, DiNardo CD, Kadia T, Yilmaz M, Maroun M, Hachem M, Borthakur G, Issa GC, Shpall EJ, Popat U, Huang X, Qiao W, Nasr L, Macaron W, Abramova R, Garcia-Manero G, Konopleva M, Ravandi F.   +21 more
europepmc   +1 more source

Enantioselective Synthesis of 2-Oxabicyclo[2.1.1]hexanes and Bicyclo[2.1.1]hexanes via Catalytic Asymmetric Intramolecular Photocycloadditions. [PDF]

Nat Commun
Tian D, Qu C, Cao S, Yu B, Zhao X, Zhang J, Jiang Z.   +6 more
europepmc   +1 more source

Switchable annulation paths to diverse N-bridged bicyclic scaffolds via ligand-directed dicarbonylation. [PDF]

Nat Commun
Liu YK, Yang P, Wang LC, Bao ZP, Wu XF.
europepmc   +1 more source

Chiral benzo[2.2.1] α-hydroxyketones from a dirhodium(ii)/bisphosphine-catalyzed desymmetrization addition reaction. [PDF]

Chem Sci
Zhan S, Wang C, Duan L, Gu Z.
europepmc   +1 more source

Efficacy of venetoclax-obinutuzumab treatment in achieving remission of acquired von Willebrand syndrome in chronic lymphocytic leukemia. [PDF]

Ann Hematol
Morelli F, Linari S, Rapolla CM, Attanasio M, Salvianti F, Sanna A.   +5 more
europepmc   +1 more source

Defining a Therapeutic Window for Venetoclax in Post-Transplant Maintenance Therapy for High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes. [PDF]

Hematol Oncol
Lyu C, Xie T, Pu Y, Luan X, Xiao X, Zhao M, Lyu H.   +6 more
europepmc   +1 more source